Basil Systems Raises $11.5M to Bring AI-Powered Product Lifecycle Intelligence to Life Sciences
Basil Systems is transforming how pharma and medical device firms navigate complex data.

Company Name: Basil Systems
Location: Boston, MA
Industry: Life Sciences / AI-Powered Product Intelligence
Funding Details:
- Amount: $11.5M
- Investors:
- Lead: Golden Ventures
- Participants: Hearst Ventures, Argosy Capital
Purpose of Investment:
- Expand the BasilIntel SaaS platform
- Enhance product capabilities
- Accelerate deployment of data-driven insights across pharma and MedTech
Leadership:
- CEO and Founder: Anthony Cirurgiao
Product:
BasilIntel is an AI-powered SaaS platform that provides life sciences companies with a structured, indexed view of regulatory, clinical, drug, and device data. It empowers users to make faster, smarter decisions across product development, clinical strategy, risk mitigation, and real-world evidence analysis.
About Company:
Basil Systems is transforming how pharma and medical device firms navigate complex data. By unifying regulatory, post-market, and clinical intelligence into one system, it improves outcomes across quality, regulatory, commercial, and medical affairs teams. Its platform is used by top-tier life sciences organizations to streamline development and improve product performance.